University Hospital Southampton NHS Foundation Trust (UHS) has boosted its Cellular Pathology digital operations with the introduction of five PathLite Compact systems from Cirdan.
It is important to consider the ways in which a system can be mounted when thinking about implementing or upgrading a macro/gross imaging system.
The development of professional medical software is often behind the curve in both technical and design implementation. This is in part due to the slow rate of replacement of software within medical institutions. Additionally, users are often not consulted in the...
Delegates were immersed into a world where artificial intelligence and augmented reality could be the home of the new laboratory. The interactions, innovators and world-class speakers definitely added to the attraction of this conference. Never mind the picturesque setting.
Cirdan will attend and present at the Leaders in Diagnostics event in London on 7th November 2018. The event brings together diagnostic leaders from all disciplines to meet, network and share knowledge over the course of a day. The event is a catalyst for generating...
Cirdan carried out the research featured in this special report in early 2018 with the aim of determining where the future of LIS lies.
As patient and clinician expectations rise and regulation grows, laboratories must look to new technologies to ensure that they can meet both challenges
This Thursday sees Lisburn medical devices company, Cirdan host a unique international conference on what lies ahead in pathology at the Lough Erne Resort in Co. Fermanagh.
While the consensus is that clinical laboratories will benefit from adopting the latest practices, processes and digital software solutions
It is important when considering camera selection for ‘Macro’ or ‘Gross’ Imaging that users should understand the capabilities of the various devices on offer from manufacturers.
Data is a huge asset and it brings with it requirements and responsibilities on a similar scale. In many ways, the process challenges facing clinical laboratories are the same as those that affect any organisation, which means that the solution will also be similar....
We are looking forward to welcoming Dr. Irene Regan, Vice President of the Academy of Clinical Scientists and Laboratory Medicine (ACSLM) in Ireland to Pathology Horizons this September.
There is wide acceptance of the concept of genotype-phenotype correlation in cancers. This concept has been extensively explored in breast carcinogenesis.
Dr. Bankhead to speak on how novel open source software platform is revolutionizing digital pathology image analysis
We are delighted to welcome Research Scientist, Dr. Peter Bankhead to our expert panel of speakers for Pathology Horizons 2018.
In recent years, advances in the field of diagnostic medicine have provided enormous benefits to patients with cancer. However, the increase in complexity of new testing modalities in pathology and radiology has also led to new challenges in gathering all essential information and forming a coherent diagnostic message for a given case.
Clinical laboratories are an important component in the healthcare system. For example, 800 million biochemistry, haematology and other clinical tests are performed annually in the NHS
There are an increasing number of molecular assays being developed to guide patient treatments.
Digital Pathology including whole slide imaging (WSI) has the potential to make the pathology workflow and reporting a more robust and dynamic process